Literature DB >> 19894021

Borrelia burgdorferi, a great chameleon: know it to recognize it!

Iolanda Santino1, Paola Comite, Giuseppe Maria Gandolfo.   

Abstract

Borrelia burgdorferi is a spirochaete that can penetrate the blood-brain barrier in early infection and can cause endothelial damage other than central nervous system lesions. We describe a clinical case of neuroborreliosis that occurred in the absence of classical erythema migrans or arthralgia. Magnetic resonance imaging findings compatible with simil-vasculitis and demyelinating lesions associated with the presence of anti-B. burgdorferi antibodies in the plasma or cerebrospinal liquid is an indication for antimicrobial treatment against B. burgdorferi. An early diagnosis and a prompt establishment of an adequate antibiotic treatment is needed for a successful recovery.

Entities:  

Mesh:

Year:  2009        PMID: 19894021     DOI: 10.1007/s10072-009-0175-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  25 in total

Review 1.  Lyme neuroborreliosis: infection, immunity, and inflammation.

Authors:  Andrew R Pachner; Israel Steiner
Journal:  Lancet Neurol       Date:  2007-06       Impact factor: 44.182

2.  Bilateral retrobulbar optic neuritis as first signs of Lyme disease.

Authors:  Ljubica Todorovic; Mirsad Ibisevic; Azra Alajbegovic; Enra Suljic-Mehmedika; Vesna Jurisic
Journal:  Med Arh       Date:  2008

3.  Multiple cranial nerve involvement in Bannwarth's syndrome.

Authors:  Marika Vianello; Giancarlo Marchiori; Bruno Giometto
Journal:  Neurol Sci       Date:  2008-05-16       Impact factor: 3.307

4.  [Neuroborreliosis with extensive cerebral vasculitis and multiple cerebral infarcts].

Authors:  A B Schmitt; W Küker; W Nacimiento
Journal:  Nervenarzt       Date:  1999-02       Impact factor: 1.214

5.  Prevalence of IgG antibodies against Borrelia Burgdorferi s.l. and Ehrlichia Phagocytophila in sera of patients presenting symptoms of Lyme disease in a central region of Italy.

Authors:  I. Santino; R. Grillo; M. Nicoletti; D. Santapaola; D. Speziale; R. Sessa; G. Fadda; M. Del Piano
Journal:  Int J Immunopathol Pharmacol       Date:  2002 Sep-Dec       Impact factor: 3.219

6.  The expanding clinical spectrum of ocular lyme borreliosis.

Authors:  H O Mikkilä; I J Seppälä; M K Viljanen; M P Peltomaa; A Karma
Journal:  Ophthalmology       Date:  2000-03       Impact factor: 12.079

7.  Bilateral facial nerve palsy: four case reports.

Authors:  G Arias; J Nogués; M Mañós; E Amilibia; M Dicenta
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1998 Jul-Aug       Impact factor: 1.538

8.  Detection of four Borrelia burgdorferi genospecies and first report of human granulocytic ehrlichiosis agent in Ixodes ricinus ticks collected in central Italy.

Authors:  I Santino; M del Piano; R Sessa; G Favia; A Iori
Journal:  Epidemiol Infect       Date:  2002-08       Impact factor: 2.451

9.  Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  J J Halperin; E D Shapiro; E Logigian; A L Belman; L Dotevall; G P Wormser; L Krupp; G Gronseth; C T Bever
Journal:  Neurology       Date:  2007-05-23       Impact factor: 9.910

10.  Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis.

Authors:  A P van Dam; H Kuiper; K Vos; A Widjojokusumo; B M de Jongh; L Spanjaard; A C Ramselaar; M D Kramer; J Dankert
Journal:  Clin Infect Dis       Date:  1993-10       Impact factor: 9.079

View more
  2 in total

1.  Lyme disease: case report of persistent Lyme disease from Pulaski County, Virginia.

Authors:  James R Palmieri; Scott King; Matthew Case; Arben Santo
Journal:  Int Med Case Rep J       Date:  2013-12-05

2.  Characteristics of Lyme optic neuritis: a case report of Lyme associated bilateral optic neuritis and systematic review of the literature.

Authors:  Yezhong Lu; Ramin Zand
Journal:  BMC Neurol       Date:  2022-03-23       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.